---
title: Testing new Parkinson treatment approach
nct_id: NCT07488351
status: RECRUITING
sponsor: Acibadem University
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07488351"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07488351"
last_fetched: "2026-07-15T14:01:45.423Z"
source: "Parkinson's Pathways (curated)"
---
# Testing new Parkinson treatment approach

**Goal (in five words):** Testing new Parkinson treatment approach

**Official Title:** "Associations of Self-Compassion and Self-Efficacy With Symptom Severity, Functional Status, and Quality of Life in Individuals With Parkinson's Disease: A Cross-Sectional Study"

**Trial ID:** [NCT07488351](https://clinicaltrials.gov/study/NCT07488351)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Acibadem University
- **Target Enrollment:** 100 participants
- **Start Date:** 2026-03-30
- **Completion Date:** 2026-12-30
- **Conditions:** Parkinson Disease, Physical Disability
- **Interventions:** Self-Report Questionnaire Assessment
- **Intervention Types:** OTHER

## Summary For Families

Researchers want to see whether people’s self-compassion and their confidence in managing Parkinson's relate to how severe their symptoms are, how well they function day-to-day, and their overall quality of life. Participants complete self-report questionnaires about kindness toward themselves, confidence in handling their condition, symptoms, daily function, and life quality, and researchers look for connections in those responses; no new treatment is given. The study is enrolling people aged 40 to 85 with a clinical diagnosis of Parkinson's at early to mid stages (stage 1 to 3), who can pass a short thinking and memory check (score 24 or higher), can complete the assessments and consent in writing, and do not have major depression, psychosis, advanced dementia, or other serious health problems that would affect testing.

## What This Actually Involves

**Placebo** _(From the protocol)_: This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.

**Visits** _(Ask the coordinator)_: Ask the coordinator how many in-person visits the study involves, how long each one takes, and over what total period.

**Procedures** _(From the protocol)_:
- Questionnaires & surveys (Non-invasive)
  > "Self-Report Questionnaire Assessment"

**Washout** _(Ask the coordinator)_: Ask the coordinator whether you would need to stop or pause any of your current medications before or during the study (a washout period), and for how long.

**Travel & reimbursement** _(Ask the coordinator)_: Ask the coordinator whether travel, parking, or your time is reimbursed or compensated, and what is covered.

_Fields marked “From the protocol” come from the trial's registry record or quoted protocol text. Fields marked “Ask the coordinator” are not reliably available and should be confirmed directly._

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Clinical diagnosis of Parkinson's disease
* Hoehn and Yahr stage 1-3
* Age 40 to 85 years
* Mini-Mental State Examination (MMSE) score ≥24
* Sufficient cognitive function to communicate and complete study assessments
* Attending the Movement Disorders Outpatient Clinic, Department of Neurology
* Able and willing to provide written informed consent

Exclusion Criteria:

* Major depressive disorder or psychotic disorder
* Advanced dementia
* Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
* Severe cardiovascular or respiratory disease
* Additional neurological or orthopedic conditions that may affect assessment performance
* Severe visual or hearing impairment that could interfere with study assessments
* Inability to cooperate with the physiotherapist during study assessments
```

## Locations (1)

- Acibadem University, Istanbul, Turkey, Turkey (Türkiye) _(41.0138, 28.9497)_
  - Nuray ALACA, (CONTACT), 05324251290, nuray.alaca@acibadem.edu.tr

## Central Contacts

- Nuray ALACA, (CONTACT), 05324251290, nuray.alaca@acibadem.edu.tr

---

*Canonical: https://parkinsonspathways.com/trial/NCT07488351*  
*HTML version: https://parkinsonspathways.com/trial/NCT07488351*  
*Source data: https://clinicaltrials.gov/study/NCT07488351*